(19)
(11) EP 3 846 816 A1

(12)

(43) Date of publication:
14.07.2021 Bulletin 2021/28

(21) Application number: 19858466.6

(22) Date of filing: 06.09.2019
(51) International Patent Classification (IPC): 
A61K 31/497(2006.01)
A61P 25/16(2006.01)
A61P 25/28(2006.01)
A61K 31/496(2006.01)
(86) International application number:
PCT/US2019/049927
(87) International publication number:
WO 2020/051435 (12.03.2020 Gazette 2020/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.09.2018 US 201816124974
08.10.2018 US 201816154301

(71) Applicant: Wayne State University
Detroit, MI 48202 (US)

(72) Inventor:
  • DUTTA, Aloke K.
    Troy, Michigan 48098 (US)

(74) Representative: GPI Brevets 
1330, rue Guillibert de la Lauzière EuroParc de Pichaury Bât B2
13856 Aix en Provence Cedex 3
13856 Aix en Provence Cedex 3 (FR)

   


(54) NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES